{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "TMB",
    "data": {
        "bs": [
            {
                "label": "Operating lease liabilities - long-term",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1821000
            },
            {
                "label": "Total Liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 8182000
            },
            {
                "label": "Common stock issuable, 52,019 and 2,103,122 shares as of June 30, 2021 and December 31, 2020, respectively",
                "concept": "CommonStockSharesSubscriptions",
                "unit": "usd",
                "value": 185000
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1386000
            },
            {
                "label": "Other receivables - related party",
                "concept": "OtherReceivables",
                "unit": "usd",
                "value": 32000
            },
            {
                "label": "Total Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 143207000
            },
            {
                "label": "Operating lease liabilities - short-term",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 346000
            },
            {
                "label": "Total Liabilities and Stockholders' Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 143207000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 6361000
            },
            {
                "label": "Fixed assets - construction in process",
                "concept": "mbio:ConstructionInProcessNet",
                "unit": "usd",
                "value": 2355000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "mbio:PropertyPlantAndEquipmentExcludingAssetsUnderConstruction",
                "unit": "usd",
                "value": 7155000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 5766000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 5766000
            },
            {
                "label": "Total Stockholders' Equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 135025000
            },
            {
                "label": "Total Stockholders' Equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 135025000
            },
            {
                "label": "Total Stockholders' Equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 135025000
            },
            {
                "label": "Operating lease right-of-use asset, net",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1101000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 129923000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 129923000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 349621000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 255000
            },
            {
                "label": "Payables and accrued expenses - related party",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 249000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -214790000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -214800000.0
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 131341000
            }
        ],
        "cf": [
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 934000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 900000.0
            },
            {
                "label": "Amortization of operating lease right-of-use assets",
                "concept": "mbio:OperatingLeaseRightOfUseAssetsAmortization",
                "unit": "usd",
                "value": 68000
            },
            {
                "label": "Offering costs for the issuance of common shares - Public Offering, in accounts payable and accrued expenses",
                "concept": "mbio:OfferingCostsForIssuanceOfCommonSharesPublicOfferingInAccountsPayableAndAccruedExpenses",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accretion of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -2899000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -324000
            },
            {
                "label": "Issuance of common shares - Equity fee on At-the-Market Offering to Fortress Biotech",
                "concept": "mbio:IssuanceOfCommonSharesEquityFeeOnAtMarketOffering",
                "unit": "usd",
                "value": 1586000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 62693000
            },
            {
                "label": "Proceeds from issuance of common shares - At-the-Market Offering",
                "concept": "mbio:ProceedsFromIssuanceOfCommonSharesAtMarketOffering",
                "unit": "usd",
                "value": 63773000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -27675000
            },
            {
                "label": "Purchase of fixed assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 2149000
            },
            {
                "label": "Proceeds from issuance of common shares under ESPP",
                "concept": "ProceedsFromStockPlans",
                "unit": "usd",
                "value": 158000
            },
            {
                "label": "Issuance of common shares - Equity fee on Public Offering to Fortress Biotech",
                "concept": "mbio:IssuanceOfCommonSharesEquityFeeOnPublicOffering",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Fixed assets (acquired but not paid)",
                "concept": "CapitalExpendituresIncurredButNotYetPaid",
                "unit": "usd",
                "value": 298000
            },
            {
                "label": "Research and development licenses included in accounts payable and accrued expenses",
                "concept": "mbio:ResearchAndDevelopmentLicensesExpenditureIncurredButNotYetPaid",
                "unit": "usd",
                "value": 250000
            },
            {
                "label": "Stock-based compensation expenses",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1543000
            },
            {
                "label": "Stock-based compensation expenses",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1543000
            },
            {
                "label": "Offering costs for the issuance of common shares - At-the-Market Offering",
                "concept": "mbio:OfferingCostsForIssuanceOfCommonSharesAtMarketOffering",
                "unit": "usd",
                "value": 1238000
            },
            {
                "label": "Offering costs for the issuance of common shares - Public Offering",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Payable and accrued expenses - related party",
                "concept": "IncreaseDecreaseInDueToRelatedParties",
                "unit": "usd",
                "value": -241000
            },
            {
                "label": "Lease liabilities",
                "concept": "mbio:IncreaseDecreaseInLeaseLiabilities",
                "unit": "usd",
                "value": 142000
            },
            {
                "label": "Research and development - licenses acquired",
                "concept": "mbio:ResearchAndDevelopmentLicenseInAccountsPayableAndAccruedExpense",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "Issuance of common shares - Founders Agreement",
                "concept": "StockIssued1",
                "unit": "usd",
                "value": 7577000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -29316000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -29316000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -29316000
            },
            {
                "label": "Other receivables - related party",
                "concept": "IncreaseDecreaseInOtherReceivables",
                "unit": "usd",
                "value": 17000
            },
            {
                "label": "Lease liabilities arising from obtaining right-of-use assets",
                "concept": "mbio:LeaseLiabilitiesArisingFromObtainingRightOfUseAssets",
                "unit": "usd",
                "value": 81000
            },
            {
                "label": "Proceeds from issuance of common shares - Public Offering",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "mbio:IncreaseDecreaseInAccountsPayableAndAccruedExpensesExcludingAmountsDueToRelatedParties",
                "unit": "usd",
                "value": -3414000
            },
            {
                "label": "Net change in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 32119000
            },
            {
                "label": "Purchase of research and development licenses",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 750000
            }
        ],
        "ic": [
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -29527000
            },
            {
                "label": "Net loss per common share outstanding, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.35
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 22520000
            },
            {
                "label": "Net Loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -29316000
            },
            {
                "label": "Net Loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -29316000
            },
            {
                "label": "Net Loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -29316000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 29527000
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOther",
                "unit": "usd",
                "value": 219000
            },
            {
                "label": "Research and development - licenses acquired",
                "concept": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
                "unit": "usd",
                "value": 1000000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 6007000
            },
            {
                "label": "Total other income (expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 211000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 8000
            },
            {
                "label": "Weighted average number of common shares outstanding, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 84033508
            }
        ]
    }
}